REGULATED PRESS RELEASE
News
-
-
-
-
-
-
REGULATED PRESS RELEASE
Obesity: Biophytis Charts Its Course Toward a Booming Market
Biophy.s SA is focusing on developing transformative therapies for obesity, sarcopenia, and longevity by addressing muscle loss with its lead drug BIO101. The company's strategic positioning targets the expanding obesity market -
REGULATED PRESS RELEASE
Obésité : Biophytis Trace sa Voie vers un Marché en Pleine Explosion
BiophyFs SA saisit une opportunité majeure sur le marché de l'obésité en pleine expansion en développant des thérapies pour préserver la masse musculaire. Focusing sur BIO101 et l'importance de la préservation musculaire dans l'obésité -
-
-
REGULATED PRESS RELEASE
Biophythis Powers Innovation in Obesity, Muscle Health, and Longevity at BIO International 2025
Biophytis highlights innovations in obesity, muscle health, and longevity at BIO International 2025, showcasing therapies targeting key health challenges. Strategic partnerships post-conference aim to accelerate therapies' global impact
